# Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)

> **NCT04120961** · NA · COMPLETED · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 330 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** prolonged continuous use of bivalirudin
- **DRUG:** bivalirudin use during ePCI

## Key facts

- **NCT ID:** NCT04120961
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-20
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04120961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04120961, "Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04120961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*